U.S. Rep. Paul Tonko (D-NY) announced a New York company would receive a $224,000 grant to improve virtual addiction treatment programs.
The company, Kaden Health, will receive the Small Business Innovation Research grant from the National Science Foundation to “establish the technical merit, feasibility and commercial potential” for the company’s proposed program.
“The ongoing COVID-19 pandemic has taken a heavy toll especially for those among us who have lost access to critical health services including mental health support and addiction treatment,” Congressman Tonko said. “Now, more than ever, our family, friends, and neighbors struggling with the disease of addiction need our support. Creating and maintaining safe, effective, and most importantly, accessible treatment programs has the potential to save countless lives. My heartfelt congratulations to the team of visionaries at Kaden Health who are working to advance this vital project. We have a long road ahead to ensure those battling substance use disorder have the support they need to find and follow the path to recovery.”
Kaden Health, formerly Thrivee, provides virtual opioid addiction treatment through personalized services and advanced tech for individuals with opioid use disorder (OUD).
“All of us at Kaden are pleased to be working with the NSF on research that helps people reclaim their lives through the use of Artificial Intelligence and Machine Learning suites of tools,” said Matt Bemis, Head of Technology at Kaden Health. “We’re constantly enhancing treatment programs to help people who are struggling with addiction — which is especially difficult during COVID-19. Kaden is a leader in breaking through traditional and staid modes of operating by innovating and employing disruptive technologies to push the healthcare industry forward.”